Conventional Anti-glioblastoma Chemotherapy Affects Proteoglycan Composition of Brain Extracellular Matrix in Rat Experimental Model in vivo

Temozolomide (TMZ) is a conventional chemotherapy drug for adjuvant treatment of glioblastoma multiforme (GBM), often accompanied by dexamethasone (DXM) to prevent brain oedema and alleviate clinical side effects. Here, we aimed to investigate an ability of the drugs to affect normal brain tissue in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsidulko, Alexandra Y., Bezier, Cynthia, de La Bourdonnaye, Gabin, Suhovskih, Anastasia V., Pankova, Tatiana M., Kazanskaya, Galina M., Aidagulova, Svetlana V., Grigorieva, Elvira V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176078/
https://www.ncbi.nlm.nih.gov/pubmed/30333749
http://dx.doi.org/10.3389/fphar.2018.01104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176078/
https://www.ncbi.nlm.nih.gov/pubmed/30333749
http://dx.doi.org/10.3389/fphar.2018.01104

Ejemplares similares